Reddy-Cheminor, Inc.
Records under this name other than patents Reddy-Cheminor, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,114,526 | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases Formerly held Term ended Term ended Jul 14, 2019 · From the USPTO record | Term ended | Term ended Jul 14, 2019 | From the USPTO record |
| US 6,372,750 | Novel heterocyclic compounds, process for their preparation and pharmaceutical compounds containing them and their use in the treatment of diabetes and related diseases Formerly held Term ended Term ended Dec 31, 2016 · Medium confidence | Term ended | Term ended Dec 31, 2016 | Medium confidence |
| US 6,573,268 | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases Formerly held Term ended Term ended Dec 31, 2016 · From the USPTO record | Term ended | Term ended Dec 31, 2016 | From the USPTO record |
| US 6,780,992 | Novel Heterocyclic Compounds, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in the Treatment of Diabetes and Related Diseases Formerly held Term ended Term ended Dec 31, 2016 · Medium confidence | Term ended | Term ended Dec 31, 2016 | Medium confidence |
| US 6,369,067 | Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them Formerly held Lapsed on the fee record Ended Apr 9, 2014 · From the USPTO record | Lapsed on the fee record | Ended Apr 9, 2014 | From the USPTO record |
| US 6,313,113 | Heterocyclic compounds having antidiabetic, hypolipidemic and antihypertensive properties, process for their preparation and pharmaceutical compositions containing them Formerly held Lapsed on the fee record Ended Nov 6, 2013 · From the USPTO record | Lapsed on the fee record | Ended Nov 6, 2013 | From the USPTO record |
| US 6,265,401 | Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them Formerly held Lapsed on the fee record Ended Jul 24, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jul 24, 2013 | From the USPTO record |
| US 6,846,824 | Novel Bicyclic Compounds and Their Use in Medicine; Process for Their Preparation and Pharmaceutical Compositions Containing Them Formerly held Lapsed on the fee record Ended Jan 25, 2013 · Medium confidence | Lapsed on the fee record | Ended Jan 25, 2013 | Medium confidence |
| US 6,177,439 | Water soluble analogues of 20(S)-camptothecin Formerly held Lapsed on the fee record Ended Jan 23, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jan 23, 2013 | From the USPTO record |
| US 6,809,095 | Bicyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them Formerly held Lapsed on the fee record Ended Oct 26, 2012 · From the USPTO record | Lapsed on the fee record | Ended Oct 26, 2012 | From the USPTO record |